ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

March 1, 1974

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977

Another Flat Budget For NIH And NCI Despite Strong Bipartisan Support.

January 11, 2008

Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around

December 7, 1979